|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02162 KEYMED BIO-B
Nominal 
32.600 -0.300 (-0.912%) Ranking Overview
Ranking based on 2 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
2
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | -137.00 RMB (cts) | |
| Net Profit | -359.36 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | -726.06 | -259.60 | 0 | -- | -710.12 | -742.00 |
| 2025 | -840.62 | -300.50 | 0 | -- | -761.00 | -920.23 |
| 2026 | -536.12 | -191.85 | 0 | -- | -500.00 | -572.23 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | -710.12 | -254.00 | -- | HUATAI FIN HLDGS HK | Buy | 60.93 | 18/11/2024 | |
| 2024 | -742.00 | -265.20 | -- | CITIGROUP | Buy | 60.00 | 11/09/2024 | |
| 2025 | -920.23 | -329.00 | -- | HUATAI FIN HLDGS HK | -- | -- | 18/11/2024 | |
| 2025 | -761.00 | -272.00 | -- | CITIGROUP | -- | -- | 11/09/2024 | |
| 2026 | -572.23 | -205.00 | -- | HUATAI FIN HLDGS HK | -- | -- | 18/11/2024 | |
| 2026 | -500.00 | -178.70 | -- | CITIGROUP | -- | -- | 11/09/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 20/12/2024 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -336,745,000 |
| %Change | -- |
| EPS / (LPS) | RMB -1.290 |
| NBV Per Share (¥) | RMB 9.426 |